Global Non-Opioid Pain Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Opioid Pain Treatment Market Size 2017-2028

2.1.2 Non-Opioid Pain Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-Opioid Pain Treatment Segment by Type

2.2.1 Medical Cannabis Treatment

2.2.2 Capsaicin-derived Treatment

2.2.3 Menthol-containing Treatment

2.2.4 Omega 3 fatty acid-containing Treatment

2.2.5 Botulinum Toxins

2.3 Non-Opioid Pain Treatment Market Size by Type

2.3.1 Non-Opioid Pain Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

2.4 Non-Opioid Pain Treatment Segment by Application

2.4.1 Orthopaedic and Musculoskeletal Pain

2.4.2 Neuropathic Pain

2.4.3 Cancer Pain

2.4.4 Others

2.5 Non-Opioid Pain Treatment Market Size by Application

2.5.1 Non-Opioid Pain Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

3 Non-Opioid Pain Treatment Market Size by Player

3.1 Non-Opioid Pain Treatment Market Size Market Share by Players

3.1.1 Global Non-Opioid Pain Treatment Revenue by Players (2020-2022)

3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Non-Opioid Pain Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-Opioid Pain Treatment by Regions

4.1 Non-Opioid Pain Treatment Market Size by Regions (2017-2022)

4.2 Americas Non-Opioid Pain Treatment Market Size Growth (2017-2022)

4.3 APAC Non-Opioid Pain Treatment Market Size Growth (2017-2022)

4.4 Europe Non-Opioid Pain Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-Opioid Pain Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-Opioid Pain Treatment Market Size by Country (2017-2022)

5.2 Americas Non-Opioid Pain Treatment Market Size by Type (2017-2022)

5.3 Americas Non-Opioid Pain Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-Opioid Pain Treatment Market Size by Region (2017-2022)

6.2 APAC Non-Opioid Pain Treatment Market Size by Type (2017-2022)

6.3 APAC Non-Opioid Pain Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-Opioid Pain Treatment by Country (2017-2022)

7.2 Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022)

7.3 Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-Opioid Pain Treatment by Region (2017-2022)

8.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-Opioid Pain Treatment Market Forecast

10.1 Global Non-Opioid Pain Treatment Forecast by Regions (2023-2028)

10.1.1 Global Non-Opioid Pain Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Non-Opioid Pain Treatment Forecast

10.1.3 APAC Non-Opioid Pain Treatment Forecast

10.1.4 Europe Non-Opioid Pain Treatment Forecast

10.1.5 Middle East & Africa Non-Opioid Pain Treatment Forecast

10.2 Americas Non-Opioid Pain Treatment Forecast by Country (2023-2028)

10.2.1 United States Non-Opioid Pain Treatment Market Forecast

10.2.2 Canada Non-Opioid Pain Treatment Market Forecast

10.2.3 Mexico Non-Opioid Pain Treatment Market Forecast

10.2.4 Brazil Non-Opioid Pain Treatment Market Forecast

10.3 APAC Non-Opioid Pain Treatment Forecast by Region (2023-2028)

10.3.1 China Non-Opioid Pain Treatment Market Forecast

10.3.2 Japan Non-Opioid Pain Treatment Market Forecast

10.3.3 Korea Non-Opioid Pain Treatment Market Forecast

10.3.4 Southeast Asia Non-Opioid Pain Treatment Market Forecast

10.3.5 India Non-Opioid Pain Treatment Market Forecast

10.3.6 Australia Non-Opioid Pain Treatment Market Forecast

10.4 Europe Non-Opioid Pain Treatment Forecast by Country (2023-2028)

10.4.1 Germany Non-Opioid Pain Treatment Market Forecast

10.4.2 France Non-Opioid Pain Treatment Market Forecast

10.4.3 UK Non-Opioid Pain Treatment Market Forecast

10.4.4 Italy Non-Opioid Pain Treatment Market Forecast

10.4.5 Russia Non-Opioid Pain Treatment Market Forecast

10.5 Middle East & Africa Non-Opioid Pain Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Non-Opioid Pain Treatment Market Forecast

10.5.2 South Africa Non-Opioid Pain Treatment Market Forecast

10.5.3 Israel Non-Opioid Pain Treatment Market Forecast

10.5.4 Turkey Non-Opioid Pain Treatment Market Forecast

10.5.5 GCC Countries Non-Opioid Pain Treatment Market Forecast

10.6 Global Non-Opioid Pain Treatment Forecast by Type (2023-2028)

10.7 Global Non-Opioid Pain Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Allergan PLC

11.1.1 Allergan PLC Company Information

11.1.2 Allergan PLC Non-Opioid Pain Treatment Product Offered

11.1.3 Allergan PLC Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Allergan PLC Main Business Overview

11.1.5 Allergan PLC Latest Developments

11.2 Canopy Growth

11.2.1 Canopy Growth Company Information

11.2.2 Canopy Growth Non-Opioid Pain Treatment Product Offered

11.2.3 Canopy Growth Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Canopy Growth Main Business Overview

11.2.5 Canopy Growth Latest Developments

11.3 Medical Marijuana Inc.

11.3.1 Medical Marijuana Inc. Company Information

11.3.2 Medical Marijuana Inc. Non-Opioid Pain Treatment Product Offered

11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Medical Marijuana Inc. Main Business Overview

11.3.5 Medical Marijuana Inc. Latest Developments

11.4 Panag Pharma Inc.

11.4.1 Panag Pharma Inc. Company Information

11.4.2 Panag Pharma Inc. Non-Opioid Pain Treatment Product Offered

11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Panag Pharma Inc. Main Business Overview

11.4.5 Panag Pharma Inc. Latest Developments

11.5 Tilray

11.5.1 Tilray Company Information

11.5.2 Tilray Non-Opioid Pain Treatment Product Offered

11.5.3 Tilray Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Tilray Main Business Overview

11.5.5 Tilray Latest Developments

11.6 Aphria Inc.

11.6.1 Aphria Inc. Company Information

11.6.2 Aphria Inc. Non-Opioid Pain Treatment Product Offered

11.6.3 Aphria Inc. Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Aphria Inc. Main Business Overview

11.6.5 Aphria Inc. Latest Developments

11.7 Bedrocan

11.7.1 Bedrocan Company Information

11.7.2 Bedrocan Non-Opioid Pain Treatment Product Offered

11.7.3 Bedrocan Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bedrocan Main Business Overview

11.7.5 Bedrocan Latest Developments

11.8 Cara Therapeutics

11.8.1 Cara Therapeutics Company Information

11.8.2 Cara Therapeutics Non-Opioid Pain Treatment Product Offered

11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Cara Therapeutics Main Business Overview

11.8.5 Cara Therapeutics Latest Developments

11.9 Centrexion Therapeutics

11.9.1 Centrexion Therapeutics Company Information

11.9.2 Centrexion Therapeutics Non-Opioid Pain Treatment Product Offered

11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Centrexion Therapeutics Main Business Overview

11.9.5 Centrexion Therapeutics Latest Developments

11.10 CHT Medical

11.10.1 CHT Medical Company Information

11.10.2 CHT Medical Non-Opioid Pain Treatment Product Offered

11.10.3 CHT Medical Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 CHT Medical Main Business Overview

11.10.5 CHT Medical Latest Developments

11.11 Cronos Group

11.11.1 Cronos Group Company Information

11.11.2 Cronos Group Non-Opioid Pain Treatment Product Offered

11.11.3 Cronos Group Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Cronos Group Main Business Overview

11.11.5 Cronos Group Latest Developments

11.12 GW Pharmaceuticals

11.12.1 GW Pharmaceuticals Company Information

11.12.2 GW Pharmaceuticals Non-Opioid Pain Treatment Product Offered

11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 GW Pharmaceuticals Main Business Overview

11.12.5 GW Pharmaceuticals Latest Developments

11.13 Medropharm Gmbh

11.13.1 Medropharm Gmbh Company Information

11.13.2 Medropharm Gmbh Non-Opioid Pain Treatment Product Offered

11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Medropharm Gmbh Main Business Overview

11.13.5 Medropharm Gmbh Latest Developments

11.14 US Worldmeds LLC

11.14.1 US Worldmeds LLC Company Information

11.14.2 US Worldmeds LLC Non-Opioid Pain Treatment Product Offered

11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 US Worldmeds LLC Main Business Overview

11.14.5 US Worldmeds LLC Latest Developments

12 Research Findings and Conclusion

Table 1. Non-Opioid Pain Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Medical Cannabis Treatment

Table 3. Major Players of Capsaicin-derived Treatment

Table 4. Major Players of Menthol-containing Treatment

Table 5. Major Players of Omega 3 fatty acid-containing Treatment

Table 6. Major Players of Botulinum Toxins

Table 7. Non-Opioid Pain Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Non-Opioid Pain Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

Table 10. Non-Opioid Pain Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Non-Opioid Pain Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global Non-Opioid Pain Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Non-Opioid Pain Treatment Revenue Market Share by Player (2020-2022)

Table 15. Non-Opioid Pain Treatment Key Players Head office and Products Offered

Table 16. Non-Opioid Pain Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Non-Opioid Pain Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Non-Opioid Pain Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas Non-Opioid Pain Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Non-Opioid Pain Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas Non-Opioid Pain Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas Non-Opioid Pain Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC Non-Opioid Pain Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Non-Opioid Pain Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC Non-Opioid Pain Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC Non-Opioid Pain Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe Non-Opioid Pain Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Non-Opioid Pain Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Non-Opioid Pain Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Non-Opioid Pain Treatment

Table 46. Key Market Challenges & Risks of Non-Opioid Pain Treatment

Table 47. Key Industry Trends of Non-Opioid Pain Treatment

Table 48. Global Non-Opioid Pain Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Non-Opioid Pain Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Non-Opioid Pain Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Non-Opioid Pain Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Non-Opioid Pain Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Non-Opioid Pain Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. Allergan PLC Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 55. Allergan PLC Non-Opioid Pain Treatment Product Offered

Table 56. Allergan PLC Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Allergan PLC Main Business

Table 58. Allergan PLC Latest Developments

Table 59. Canopy Growth Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 60. Canopy Growth Non-Opioid Pain Treatment Product Offered

Table 61. Canopy Growth Main Business

Table 62. Canopy Growth Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Canopy Growth Latest Developments

Table 64. Medical Marijuana Inc. Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 65. Medical Marijuana Inc. Non-Opioid Pain Treatment Product Offered

Table 66. Medical Marijuana Inc. Main Business

Table 67. Medical Marijuana Inc. Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Medical Marijuana Inc. Latest Developments

Table 69. Panag Pharma Inc. Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 70. Panag Pharma Inc. Non-Opioid Pain Treatment Product Offered

Table 71. Panag Pharma Inc. Main Business

Table 72. Panag Pharma Inc. Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Panag Pharma Inc. Latest Developments

Table 74. Tilray Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 75. Tilray Non-Opioid Pain Treatment Product Offered

Table 76. Tilray Main Business

Table 77. Tilray Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Tilray Latest Developments

Table 79. Aphria Inc. Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 80. Aphria Inc. Non-Opioid Pain Treatment Product Offered

Table 81. Aphria Inc. Main Business

Table 82. Aphria Inc. Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Aphria Inc. Latest Developments

Table 84. Bedrocan Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 85. Bedrocan Non-Opioid Pain Treatment Product Offered

Table 86. Bedrocan Main Business

Table 87. Bedrocan Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Bedrocan Latest Developments

Table 89. Cara Therapeutics Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 90. Cara Therapeutics Non-Opioid Pain Treatment Product Offered

Table 91. Cara Therapeutics Main Business

Table 92. Cara Therapeutics Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Cara Therapeutics Latest Developments

Table 94. Centrexion Therapeutics Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 95. Centrexion Therapeutics Non-Opioid Pain Treatment Product Offered

Table 96. Centrexion Therapeutics Main Business

Table 97. Centrexion Therapeutics Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Centrexion Therapeutics Latest Developments

Table 99. CHT Medical Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 100. CHT Medical Non-Opioid Pain Treatment Product Offered

Table 101. CHT Medical Main Business

Table 102. CHT Medical Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. CHT Medical Latest Developments

Table 104. Cronos Group Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 105. Cronos Group Non-Opioid Pain Treatment Product Offered

Table 106. Cronos Group Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Cronos Group Main Business

Table 108. Cronos Group Latest Developments

Table 109. GW Pharmaceuticals Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 110. GW Pharmaceuticals Non-Opioid Pain Treatment Product Offered

Table 111. GW Pharmaceuticals Main Business

Table 112. GW Pharmaceuticals Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. GW Pharmaceuticals Latest Developments

Table 114. Medropharm Gmbh Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 115. Medropharm Gmbh Non-Opioid Pain Treatment Product Offered

Table 116. Medropharm Gmbh Main Business

Table 117. Medropharm Gmbh Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Medropharm Gmbh Latest Developments

Table 119. US Worldmeds LLC Details, Company Type, Non-Opioid Pain Treatment Area Served and Its Competitors

Table 120. US Worldmeds LLC Non-Opioid Pain Treatment Product Offered

Table 121. US Worldmeds LLC Main Business

Table 122. US Worldmeds LLC Non-Opioid Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. US Worldmeds LLC Latest Developments

List of Figures

Figure 1. Non-Opioid Pain Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-Opioid Pain Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-Opioid Pain Treatment Market Size Market Share by Type in 2021

Figure 7. Non-Opioid Pain Treatment in Orthopaedic and Musculoskeletal Pain

Figure 8. Global Non-Opioid Pain Treatment Market: Orthopaedic and Musculoskeletal Pain (2017-2022) & ($ Millions)

Figure 9. Non-Opioid Pain Treatment in Neuropathic Pain

Figure 10. Global Non-Opioid Pain Treatment Market: Neuropathic Pain (2017-2022) & ($ Millions)

Figure 11. Non-Opioid Pain Treatment in Cancer Pain

Figure 12. Global Non-Opioid Pain Treatment Market: Cancer Pain (2017-2022) & ($ Millions)

Figure 13. Non-Opioid Pain Treatment in Others

Figure 14. Global Non-Opioid Pain Treatment Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Non-Opioid Pain Treatment Market Size Market Share by Application in 2021

Figure 16. Global Non-Opioid Pain Treatment Revenue Market Share by Player in 2021

Figure 17. Global Non-Opioid Pain Treatment Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Non-Opioid Pain Treatment Market Size 2017-2022 ($ Millions)

Figure 19. APAC Non-Opioid Pain Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Europe Non-Opioid Pain Treatment Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Non-Opioid Pain Treatment Market Size 2017-2022 ($ Millions)

Figure 22. Americas Non-Opioid Pain Treatment Value Market Share by Country in 2021

Figure 23. Americas Non-Opioid Pain Treatment Consumption Market Share by Type in 2021

Figure 24. Americas Non-Opioid Pain Treatment Market Size Market Share by Application in 2021

Figure 25. United States Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Non-Opioid Pain Treatment Market Size Market Share by Region in 2021

Figure 30. APAC Non-Opioid Pain Treatment Market Size Market Share by Application in 2021

Figure 31. China Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Non-Opioid Pain Treatment Market Size Market Share by Country in 2021

Figure 38. Europe Non-Opioid Pain Treatment Market Size Market Share by Type in 2021

Figure 39. Europe Non-Opioid Pain Treatment Market Size Market Share by Application in 2021

Figure 40. Germany Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Non-Opioid Pain Treatment Market Size Market Share by Application in 2021

Figure 48. Egypt Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Non-Opioid Pain Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 54. APAC Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 55. Europe Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 57. United States Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Canada Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 61. China Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Japan Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 63. Korea Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 65. India Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Australia Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 67. Germany Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 68. France Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 69. UK Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Italy Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Russia Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Spain Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 75. Israel Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Non-Opioid Pain Treatment Market Size 2023-2028 ($ Millions)